先天免疫系统
获得性免疫系统
免疫系统
神经炎症
免疫学
脊髓损伤
炎症
免疫
免疫耐受
医学
神经科学
CCL18型
先天性淋巴细胞
小胶质细胞
细胞生物学
生物
细胞外
胞外囊泡
细胞外小泡
树突状细胞
巨噬细胞
作者
Tao Jia,Kunrong Xie,Jianing Zu,Jiawei Shen,Jiawen Niu,Xuefeng Li,Fawang Zhang,Hailong Zheng,Jinglong Yan,Yufu Wang
出处
期刊:Nano Research
[Springer Science+Business Media]
日期:2026-01-13
卷期号:19 (3): 94908418-94908418
被引量:2
标识
DOI:10.26599/nr.2026.94908418
摘要
An imbalance between the innate and adaptive immunity after traumatic spinal cord injury (SCI) triggers excessive inflammatory activation, which ultimately leads to secondary neuronal damage and functional impairment. Importantly, inducing tolerance in both the innate and adaptive immunity helps suppress neuroinflammation and promotes neuroprotection. Innate immune tolerance triggered by lipopolysaccharides (LPS) is rapid, specific, and long-lasting; however, direct administration may cause significant side effects. Similarly, administering self-antigens after SCI can foster adaptive immune tolerance but may worsen tissue damage. Extracellular vesicles (EVs), as highly biocompatible natural carriers that address these challenges and deliver immunoregulatory signals to establish immune-tolerant microenvironments. Therefore, we preconditioned macrophages with a combination of low-dose LPS and self-antigens (myelin debris) to induce an immune-tolerant phenotype and isolated the resulting EVs trained with low-dose LPS and self-antigens (Trained-EVs). Our results demonstrate that Trained-EVs can effectively enhance innate immune tolerance and modulate adaptive immunity, thereby establishing a tolerogenic immune microenvironment. This dual strategy for inducing tolerance is a promising immunotherapeutic option for autoimmune and inflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI